Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”
Abstract
:1. Introduction
2. Reply to the Comments
2.1. Purity of Oleocanthal and Biological Sample Analysis
2.2. Perfusion Technique
3. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Christophoridou, S.; Dais, P.; Tseng, A.L.-H.; Spraul, M. Separation and Identification of Phenolic Compounds in Olive Oil by Coupling High-Performance Liquid Chromatography with Postcolumn Solid-Phase Extraction to Nuclear Magnetic Resonance Spectroscopy (LC-SPE-NMR). J. Agric. Food Chem. 2005, 53, 4667–4679. [Google Scholar] [CrossRef] [PubMed]
- De Medina, V.S.; Miho, H.; Melliou, E.; Magiatis, P.; Priego-Capote, F.; de Castro, M.D.L. Quantitative method for determination of oleocanthal and oleacein in virgin olive oils by liquid chromatography–tandem mass spectrometry. Talanta 2017, 162, 24–31. [Google Scholar] [CrossRef] [PubMed]
- Hazas, M.-C.L.D.L.; Piñol, C.; Macià, A.; Romero, M.-P.; Pedret, A.; Solà, R.; Rubió, L.; Motilva, M.-J. Differential absorption and metabolism of hydroxytyrosol and its precursors oleuropein and secoiridoids. J. Funct. Foods 2016, 22, 52–63. [Google Scholar] [CrossRef] [Green Version]
- Serra, A.; Rubió, L.; Borràs, X.; Macià, A.; Romero, M.-P.; Motilva, M.-J. Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol. Nutr. Food Res. 2012, 56, 486–496. [Google Scholar] [CrossRef]
- Suárez, M.; Romero, M.-P.; Macià, A.; Valls, R.M.; Fernández, S.; Solà, R.; Casado, M.-J.M. Improved method for identifying and quantifying olive oil phenolic compounds and their metabolites in human plasma by microelution solid-phase extraction plate and liquid chromatography–tandem mass spectrometry. J. Chromatogr. B 2009, 877, 4097–4106. [Google Scholar] [CrossRef]
- Resch, V.; Seidler, C.; Chen, B.-S.; Degeling, I.; Hanefeld, U. On the Michael Addition of Water to α,β-Unsaturated Ketones Using Amino Acids. Eur. J. Org. Chem. 2013, 2013, 7697–7704. [Google Scholar] [CrossRef] [Green Version]
- Silva, S.; Garcia-Aloy, M.; Figueira, M.E.; Combet, E.; Mullen, W.; Ros, M. High Resolution Mass Spectrometric Analysis of Secoiridoids and Metabolites as Biomarkers of Acute Olive Oil Intake—An Approach to Study Interindividual Variability in Humans. Mol. Nutr. Food Res. 2018, 62, 1–11. [Google Scholar] [CrossRef] [Green Version]
- Orrego-Lagarón, N.; Vallverdú-Queralt, A.; Martínez-Huélamo, M.; Lamuela-Raventos, R.M.; Escribano-Ferrer, E. Metabolic profile of naringenin in the stomach and colon using liquid chromatography/electrospray ionization linear ion trap quadrupole-Orbitrap-mass spectrometry (LC-ESI-LTQ-Orbitrap-MS) and LC-ESI-MS/MS. J. Pharm. Biomed. Anal. 2016, 120, 38–45. [Google Scholar] [CrossRef]
- Ventura, G.; Calvano, C.D.; Abbattista, R.; Bianco, M.; De Ceglie, C.; Losito, I.; Palmisano, F.; Cataldi, T.R. Characterization of bioactive and nutraceutical compounds occurring in olive oil processing wastes. Rapid Commun. Mass Spectrom. 2019, 33, 1670–1681. [Google Scholar] [CrossRef]
- Kanakis, P.; Termentzi, A.; Michel, T.; Gikas, E.; Halabalaki, M.; Skaltsounis, A.-L. From Olive Drupes to Olive Oil. An HPLC-Orbitrap-based Qualitative and Quantitative Exploration of Olive Key Metabolites. Planta Med. 2013, 79, 1576–1587. [Google Scholar] [CrossRef] [Green Version]
- Taketani, M.; Shii, M.; Ohura, K.; Ninomiya, S.; Imai, T. Carboxylesterase in the liver and small intestine of experimental animals and human. Life Sci. 2007, 81, 924–932. [Google Scholar] [CrossRef] [PubMed]
- Griffin, B.T.; O’Driscoll, C. Drug Absorption Studies; Springer Science and Business Media LLC: Berlin/Heidelberg, Germany, 2007; pp. 34–76. [Google Scholar]
- Dahan, A.; Amidon, G.L. MRP2 mediated drug–drug interaction: Indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting. Int. J. Pharm. 2010, 386, 216–220. [Google Scholar] [CrossRef] [PubMed]
- Dahan, A.; West, B.T.; Amidon, G.L. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Eur. J. Pharm. Sci. 2009, 36, 320–329. [Google Scholar] [CrossRef] [PubMed]
- Zur, M.; Gasparini, M.; Wolk, O.; Amidon, G.L.; Dahan, A. The Low/High BCS Permeability Class Boundary: Physicochemical Comparison of Metoprolol and Labetalol. Mol. Pharm. 2014, 11, 1707–1714. [Google Scholar] [CrossRef]
- Incecayir, T.; Tsume, Y.; Amidon, G.L. Comparison of the Permeability of Metoprolol and Labetalol in Rat, Mouse, and Caco-2 Cells: Use as a Reference Standard for BCS Classification. Mol. Pharm. 2013, 10, 958–966. [Google Scholar] [CrossRef]
- Roos, C.; Dahlgren, D.; Sjögren, E.; Tannergren, C.; Abrahamsson, B.; Lennernäs, H. Regional Intestinal Permeability in Rats: A Comparison of Methods. Mol. Pharm. 2017, 14, 4252–4261. [Google Scholar] [CrossRef]
- Roos, C.; Dahlgren, D.; Berg, S.; Westergren, J.; Abrahamsson, B.; Tannergren, C.; Sjögren, E.; Lennernäs, H. In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations. Mol. Pharm. 2017, 14, 4233–4242. [Google Scholar] [CrossRef]
- Sutton, S.C.; Rinaldi, M.T.S.; Vukovinsky, K.E. Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS Pharmsci 2001, 3, 93–97. [Google Scholar] [CrossRef] [Green Version]
- Tuğcu-Demiröz, F.; Gonzalez-Alvarez, I.; Gonzalez-Alvarez, M.; Bermejo, M. Validation of phenol red versus gravimetric method for water reabsorption correction and study of gender differences in Doluisio’s absorption technique. Eur. J. Pharm. Sci. 2014, 62, 105–110. [Google Scholar] [CrossRef]
- Li, W.B.; Luo, B.F.; Wang, R.; Lu, H.; Wang, C.; Zhao, A.P.; Jia, Z.P. Changes of P-gp expression in rats’ small intestine and effects on uptake of levofloxacin after acute exposure to hypoxia. Yao xue xue bao = Acta Pharm. Sin. 2016, 51, 1412–1416. [Google Scholar]
- Volpe, D.A. Permeability classification of representative fluoroquinolones by a cell culture method. Aaps Pharmsci. 2004, 6, 1–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dahan, A.; Wolk, O.; Agbaria, R. Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development. Drug Des. Dev. Ther. 2014, 8, 1563–1575. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rowland, M.; Tozer, T. Clinical Pharmacokinetics Pharmacodynamics: Concepts and Applications, 5th ed.; Williams & Wilkins: Philadelphia, PA, USA, 2019; p. 78. [Google Scholar]
- Komiya, I.; Park, J.; Kamani, A.; Ho, N.; Higuchi, W. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm. 1980, 4, 249–262. [Google Scholar] [CrossRef] [Green Version]
- Qusa, M.H.; Siddique, A.B.; Nazzal, S.; El Sayed, K.A. Novel olive oil phenolic (−)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities. Int. J. Pharm. 2019, 569, 118596. [Google Scholar] [CrossRef]
- Siddique, A.B.; Ebrahim, H.; Mohyeldin, M.M.; Qusa, M.; Batarseh, Y.; Fayyad, A.; Tajmim, A.; Nazzal, S.; Kaddoumi, A.; El Sayed, K.A. Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity. PLoS ONE 2019, 14, e0214798. [Google Scholar] [CrossRef] [Green Version]
- Morais, J.A.G.; Lobato, M.D.R. The New European Medicines Agency Guideline on the Investigation of Bioequivalence. Basic Clin. Pharmacol. Toxicol. 2010, 106, 221–225. [Google Scholar] [CrossRef]
- FDA. Waiver of in Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System; US Department of Health and Human Services Food and Drug Administration: Rockville, MD, USA, 2017. [Google Scholar]
- Brouwers, J.; Mols, R.; Annaert, P.P.; Augustijns, P. Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profiling. Biopharm. Drug Dispos. 2010, 31, 278–285. [Google Scholar] [CrossRef]
- Lennernäs, H. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 1997, 49, 627–638. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
López-Yerena, A.; Vallverdú-Queralt, A.; Mols, R.; Augustijns, P.; Lamuela-Raventós, R.M.; Escribano-Ferrer, E. Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”. Pharmaceutics 2020, 12, 1221. https://doi.org/10.3390/pharmaceutics12121221
López-Yerena A, Vallverdú-Queralt A, Mols R, Augustijns P, Lamuela-Raventós RM, Escribano-Ferrer E. Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”. Pharmaceutics. 2020; 12(12):1221. https://doi.org/10.3390/pharmaceutics12121221
Chicago/Turabian StyleLópez-Yerena, Anallely, Anna Vallverdú-Queralt, Raf Mols, Patrick Augustijns, Rosa M. Lamuela-Raventós, and Elvira Escribano-Ferrer. 2020. "Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”" Pharmaceutics 12, no. 12: 1221. https://doi.org/10.3390/pharmaceutics12121221